Study of Psychiatric Status and Symptom Severity in Adults With Graft-versus-Host Disease Assessing Impact on Quality of Life and Clinical Outcomes

What this Trial Is About

This research aims to understand how psychiatric conditions relate to symptom severity and quality of life in patients with graft-versus-host disease GvHD, a serious complication after stem cell transplantation. The study focuses on assessing mental health status and symptom burden to improve support and care for these patients. It uses standardized tools to measure clinical and psychiatric factors in a systematic way. Patients with chronic GvHD, some diagnosed with depressive or adjustment disorders or cognitive impairment, will be observed to compare symptom severity and psychiatric status. The study does not involve experimental treatments but collects data from patients receiving regular care to evaluate these associations. Follow-up assessments will be conducted over a period of up to 12 months. Participants will provide clinical, psychiatric, and demographic information through validated questionnaires and clinical evaluations. The study will monitor depression levels, symptom burden using the Lee Symptom Scale, and quality of life measures. The research team will assess how psychiatric factors influence GvHD symptoms and explore the effects of different psychiatric treatments on patient outcomes during the study period.

Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).